This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

CPHI Online is the largest global marketplace in the pharma ingredients industry

  • Products
    0
  • Companies
    0
  • Articles
    0
  • Events
    0
  • Webinars
    0
News
17 Sep 2020

Nemera expands its insulin pen’s offer in Brazil

This partnership expands offer of diabetes medicines in the country; Nemera’s Advapen launch happens under the trade name Lifepen® for the administration of Glargilin insulin for the treatment of diabetes A pioneer in biotechnological medicines in Brazil, BIOMM is launching Nemera’s Advapen under the trade name Lifepen® for the administration of Glargilin insulin for the treatment of diabetes.

Nemera and Biomm sign partnership agreement to commercialize reusable insulin pen in Brazil

Mentioned Companies
Nemera
View company profile